News items Department of Medical Imaging takes fourth spot in world hospital rankings
29 October 2021

The Department of Medical Imaging at Radboudumc is ranked number four in US News & World Report's global ranking of the best universities of 2021-2022. US News annually conducts an independent assessment of hospitals around the world based on their academic science and reputation. This is how they help patients choose their care. 

"Great news," says Mathias Prokop, head of the Department of Medical Imaging at Radboudumc. "I am extremely proud of our people. This is truly a team effort. All credit to the people who make our care, education and research possible. Particularly in the United States, students and physicians use this prestigious ranking when choosing a course of study or training at a particular university."

Research in the Imaging Department focuses on technical and clinical innovations that lead to better patient outcomes and lower healthcare costs. Key topics include the early detection of lung, breast and prostate cancer and the corresponding minimally invasive treatment. Better prediction of treatment success and choosing the most appropriate treatment are also major topics. Science covers the entire spectrum of diagnostic techniques, including ultrasound, CT, MRI, nuclear medicine and artificial intelligence.

In 2020, US News expanded the list of rated courses and specialties to include Radiology and Nuclear Medicine. In 2020-2021, Radboudumc was ranked number five. In the new edition, they rise to fourth place, behind Harvard, Stanford and King's College London.

About the rankings

Click here for the ranking for medical imaging.

Click here for more information on how these rankings are created.
 

More information


Annemarie Eek

wetenschapsvoorlichter

+31 611091018
send an email

Related news items


Willem Mulder appointed professor of Precision Medicine

4 October 2022

Willem Mulder has been appointed professor of Precision Medicine at Radboud university medical center / Radboud University. He develops new drugs for immunotherapy against cancer, inflammation, rejection reactions and infectious diseases.

read more

Immune cell becomes tumor cell by a molecular switch to higher lipid uptake Protein CD37 plays an important role in the development and prognosis of B-cell lymphoma

19 September 2022

When B cells of the immune system no longer have the protein CD37 on their surface, they can change into tumor cells that form blood cancer. CD37 inhibits fat uptake in B cells. If this protein is missing, a tumor cell absorbs much more fat and therefore grows faster. 

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

New start-up Patholyt will bring AI research into pathology diagnostics

21 September 2021 Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research. read more